Lipid Subclass Analysis for Selected Patients With and Without Elevated Serum Triglyceride
Subclass . | Unaffected . | Affected . | ||
---|---|---|---|---|
(particle diameter) . | (TRI < 400 mg/dL) . | (TRI > 400 mg/dL) . | ||
. | (N = 3; mean [SD]) . | (N = 4; mean [SD]) . | ||
. | Pre . | During . | Pre . | During . |
Chylomicron (>160 nm) | 1.5 (1.4) | 1.1 (1.3) | 4.7 (4.6) | 5.6 (6.7) |
VLDL5,6 (60-160 nm) | 18.5 (5.7) | 20.3 (17.2) | 30.5 (27.9) | 396.3 (343.5) |
VLDL1-4 (30-60 nm) | 47.0 (5.9) | 27.4 (9.4) | 70.2 (33.0) | 222.0 (52.2)4-150 |
LDL3,4 (21.3-27 nm) | 38.8 (21.6) | 53.4 (42.2) | 66.8 (28.7) | 1.7 (3.5)4-151 |
LDL1,2 (18.3-21.3 nm) | 62.2 (33.8) | 41.5 (23.6) | 80.0 (52.2) | 230.2 (66.1)4-151 |
HDLTOTAL (7.3-13 nm) | 26.9 (10.8) | 32.6 (15.6) | 42.1 (19.5) | 48.2 (17.7) |
Subclass . | Unaffected . | Affected . | ||
---|---|---|---|---|
(particle diameter) . | (TRI < 400 mg/dL) . | (TRI > 400 mg/dL) . | ||
. | (N = 3; mean [SD]) . | (N = 4; mean [SD]) . | ||
. | Pre . | During . | Pre . | During . |
Chylomicron (>160 nm) | 1.5 (1.4) | 1.1 (1.3) | 4.7 (4.6) | 5.6 (6.7) |
VLDL5,6 (60-160 nm) | 18.5 (5.7) | 20.3 (17.2) | 30.5 (27.9) | 396.3 (343.5) |
VLDL1-4 (30-60 nm) | 47.0 (5.9) | 27.4 (9.4) | 70.2 (33.0) | 222.0 (52.2)4-150 |
LDL3,4 (21.3-27 nm) | 38.8 (21.6) | 53.4 (42.2) | 66.8 (28.7) | 1.7 (3.5)4-151 |
LDL1,2 (18.3-21.3 nm) | 62.2 (33.8) | 41.5 (23.6) | 80.0 (52.2) | 230.2 (66.1)4-151 |
HDLTOTAL (7.3-13 nm) | 26.9 (10.8) | 32.6 (15.6) | 42.1 (19.5) | 48.2 (17.7) |